Leaflet DOBUTAMINA PANPHARMA 250mg / 20ml concentrate for solution for infusion

Product code:
W60744001
Quantity:
1
Indicated for:
cardiogenic shock; acute heart failure
Route of administration:
infusion
Substance:
dobutamine (vasopressor)
ATC
C01CA07 — Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Adrenergic and dopaminergic agents
Dobutamine is a medication used for the treatment of acute heart failure and other conditions requiring increased cardiac contractility. It is a beta-adrenergic agonist that stimulates the heart to pump blood more efficiently.

The medication is administered intravenously, usually in a hospital setting, under medical supervision. It is effective in improving cardiac function and stabilizing patients with severe heart failure.

Side effects may include tachycardia, high blood pressure, nausea, and, in rare cases, arrhythmias. Close monitoring of cardiac function is essential during treatment.

Consult your doctor to discuss the benefits and risks of treatment with Dobutamine. This medication must be administered exclusively in controlled environments, such as hospitals.

General data about DOBUTAMINA PANPHARMA 250mg / 20ml

Substance:
dobutamine
Date of latest medicines list:
01-03-2022
Product code:
W60744001
Concentration:
250mg / 20ml
Pharmaceutical form:
concentrate for solution for infusion
Packing volume:
20 ml
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ROTEXMEDICA GMBH ARZNEIMITTELWERK - GERMANIA
Holder:
PANPHARMA - FRANTA
Number:
11686/2019/01
Shelf life:
3 years-after packing for marketing;dupa diluare-it is used immediately

Pharmaceutical forms available for dobutamine

Concentrations available for dobutamine

  • 12.5mg/ml
  • 125mg/ml
  • 250mg
  • 250mg/20ml
  • 250mg/50ml
  • 5mg/ml